Interleukin-39 exacerbates concanavalin A-induced liver injury.

CONCLUSION: Our results suggest that IL-39 can exacerbate ConA-induced hepatitis and may be a therapeutic target in inflammatory liver disease.
PMID: 33412981 [PubMed - as supplied by publisher]

Source: Immunopharmacology and Immunotoxicology - January 10, 2021 Category: Allergy & Immunology Tags: Immunopharmacol Immunotoxicol Source Type: research